- Filed
- Mar 28, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Dec 31, 2023 | 47.72M sh |
| Short Term Investments | FY 2023 · Dec 31, 2022 | $275.03M |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $104.6M |
| Current Liabilities | FY 2023 · Dec 31, 2022 | $65.37M |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $88.84M |
| Current Assets | FY 2023 · Dec 31, 2022 | $578.84M |
| Total Assets | FY 2023 · Dec 31, 2022 | $957.67M |
| Shares Diluted | FY 2023 · Dec 31, 2021 | 48.6M sh |
| Capex restated | FY 2023 · Dec 31, 2021 | $14.48M |
| Operating Cash Flow | FY 2023 · Dec 31, 2021 | $53.64M |
| Eps Diluted | FY 2023 · Dec 31, 2021 | $0.32 |
| Eps Basic | FY 2023 · Dec 31, 2021 | $0.33 |
| Sga Expense | FY 2023 · Dec 31, 2021 | $36.64M |
| Rd Expense | FY 2023 · Dec 31, 2021 | $43.73M |
| Net Income | FY 2023 · Dec 31, 2021 | $15.53M |
| Operating Income | FY 2023 · Dec 31, 2021 | $12.79M |
| Gross Profit | FY 2023 · Dec 31, 2021 | $151.91M |
| Cost Of Revenue | FY 2023 · Dec 31, 2021 | $170.1M |
| Revenue | FY 2023 · Dec 31, 2021 | $322.01M |
| Stockholders Equity | FY 2023 · Dec 31, 2020 | $519.02M |